Central Baldwin Dental Center, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 18100 Highway 104, Robertsdale, AL 36567 Phone: 251-947-5940 Fax: 251-947-5942 |
Roberto V Pischek Dmd Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 21400 State Highway 59, Robertsdale, AL 36567 Phone: 251-947-5811 Fax: 251-945-1057 |
Central Baldwin Dental Center Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 18100 Hwy 104, 18100 Hwy 104, Robertsdale, AL 36567 Phone: 251-947-5940 |
Robertsdale Dental Care Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 18471 Wilters St, Robertsdale, AL 36567 Phone: 251-947-3636 |
News Archive
Sleepiness after a large meal is something we all experience, and new research with fruit flies suggests higher protein and salt content in our food, as well as the volume consumed, can lead to longer naps.
Bariatric surgery can result in long-term weight loss and significant reductions in cardiac and other risk factors for some severely obese adults, according to a scientific statement from the American Heart Association.
Feeding older mice a lower glycemic index (GI) diet consisting of slowly-digested carbohydrates delays the onset of age-related, sight-threatening retinal lesions, according to a new study from the Laboratory for Nutrition and Vision Research at the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University.
Two existing definitions of chronic multisymptom illness (CMI) - one by the Centers for Disease Control and Prevention and another from a study of Kansas Gulf War veterans - should be used by the U.S. Department of Veterans Affairs to guide research and treatment of Gulf War veterans, says a new report from the Institute of Medicine.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of Z944, a novel oral T-type calcium channel blocker with demonstrated preclinical potential for the treatment of acute and inflammatory pain.
› Verified 2 days ago